Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Cefuroxim in parenteraler Darreichungsform (ATC-Code: J01DC02).

Conclusion of a non-exclusive rebate contract under § 130a, paragraph 8, SGB V for the prescription and dispensing of medicines with the active substance Cefuroxim in parenteral form (ATC Code: J01DC02) within the period from 01.11.2026 until 31.10.2028, with the possibility of concluding the contract at any time during the term ("open-house model"). In Niedersachsen, pharmacies must prioritise dispensing finished medicinal products for which a rebate contract under § 130a, paragraph 8, SGB V exists, even for the prescription requirement, as of 01.07.2026.